PathoFinder B.V.
PathoFinder B.V. is a Dutch molecular diagnostics company that develops CE-IVD multiplex real-time PCR kits for syndromic detection of respiratory, gastrointestinal, sexually transmitted, and central nervous system infections, sold through a global distributor network to clinical diagnostic laboratories worldwide.
- Company typePrivate
- Founded2004
- HeadquartersMaastricht, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What PathoFinder B.V. does
PathoFinder B.V. is a privately held Dutch molecular diagnostics company headquartered in Maastricht, founded in 2004 by Guus Simons, PhD. The company develops and commercializes CE-IVD multiplex real-time PCR kits for syndromic detection of infectious diseases, organized around four disease-area panels — RespiFinder 2Smart (respiratory), GastroFinder 2Smart (gastroenteritis), STD-Finder 2Smart (sexually transmitted diseases), and MeningoFinder 2Smart (central nervous system infections) — plus a RealAccurate quadruplex line of single-pathogen and sub-typing kits covering Influenza, Coronavirus, SARS-CoV-2, Parainfluenza, RSV/hMPV, Adeno/Boca/Rhino/Entero, Bordetella, atypical bacteria, and Mycobacteria.
The technical foundation rests on two proprietary platforms. SmartFinder technology (marketed as 2SmartFinder) uses Single tube Multiplex Amplification in Real-Time (SMART) chemistry with a gene-specific multiplex reverse transcription step followed by signal amplification via a single PCR primer pair, enabling detection of up to 24 pathogens per reaction via melting-curve analysis on validated real-time cyclers. RealAccurate uses standardized Taqman quadruplex chemistry across four detection channels with uniform PCR protocols. All kits are CE-IVD marked, manufactured under EN ISO 13485:2016 (certificate MD 737649, re-issued May 2025), and certified IVDR Class B (CE 750951, September 2022). Validation has been completed across extraction and detection platforms from QIAGEN (Rotor-Gene Q, QIAsymphony, QIAamp kits), Roche (LightCycler 480, MagNA Pure 96), Bio-Rad (CFX96), ThermoFisher (QuantStudio 5), bioMérieux (NucliSENS easyMAG), IT-IS Life Science (PathoCycler, MyGoPro), and Bio Molecular Systems (Mic qPCR).
Commercially, PathoFinder operates a one-time-sale B2B model, selling kits through a global distributor network of roughly 30+ named regional partners covering 40+ countries across Europe, Asia Pacific, the Middle East, Africa, South America, and North America, while maintaining direct sales channels in core European markets (Netherlands, Germany, Belgium, Austria, Switzerland, Luxembourg). End users are clinical diagnostic laboratories and hospital pathology departments performing syndromic infectious disease testing; no named end-customer accounts are disclosed. The company is founder-owned, has not raised institutional funding, and operates with a headcount in the 11–50 range.
PathoFinder B.V. firmographics
Firmographics- Name
- PathoFinder B.V.
- Legal name
- PathoFinder B.V.
- Website
- https://pathofinder.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PathoFinder B.V. is a Dutch molecular diagnostics company that develops CE-IVD multiplex real-time PCR kits for syndromic detection of respiratory, gastrointestinal, sexually transmitted, and central nervous system infections, sold through a global distributor network to clinical diagnostic laboratories worldwide.
- Ownership category
- akta.pro rank
PathoFinder B.V. industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Hematology POCT (CBC/hemoglobin/hematocrit) (HLAHAOAD)
- akta.pro secondary industry
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where PathoFinder B.V. is headquartered
LocationHeadquarters
- HQ city
- Maastricht
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
PathoFinder B.V. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D
Revenue model
- CE-IVD Multiplex PCR Kits: PathoFinder generates revenue through the sale of CE-IVD marked multiplex real-time PCR diagnostic kits for detection of infectious diseases. Products include RespiFinder 2Smart, GastroFinder 2Smart, STD-Finder 2Smart, MeningoFinder 2Smart, and various RealAccurate Quadruplex kits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
PathoFinder B.V. product offering
Product offeringCore offering
PathoFinder develops, manufactures, and sells CE-IVD marked multiplex real-time PCR diagnostic kits for syndromic detection of infectious diseases. Its portfolio includes RespiFinder 2Smart, GastroFinder 2Smart, STD-Finder 2Smart, and MeningoFinder 2Smart syndromic panels, plus nine targeted RealAccurate Quadruplex kits for specific respiratory and mycobacterial pathogens. Products are sold globally through a distributor network and validated on leading qPCR platforms.
Product overview
PathoFinder B.V. offers two core molecular diagnostic technology platforms: SmartFinder technology (for up to 24-plex detection) and RealAccurate quadruplex real-time PCR technology. The product portfolio is organized into four disease-specific syndromic panels under the 2Smart brand (RespiFinder 2Smart for respiratory infections, GastroFinder 2Smart for gastrointestinal infections, STD-Finder 2Smart for sexually transmitted diseases, and MeningoFinder 2Smart for meningitis/CNS infections), along with targeted RealAccurate quadruplex kits for specific pathogen groups including Influenza, Coronavirus, SARS-CoV-2, Parainfluenza, RSV/hMPV, Adeno/Boca/Rhino/Entero, Bordetella, Atypical bacteria, and Mycobacteria. All products are CE-IVD marked and validated on major qPCR platforms from Roche, QIAGEN, Bio-Rad, ThermoFisher, and others.
Differentiator
Problem solved
Functional benefit
Brands
- 2SmartFinder: Proprietary multiplex PCR technology enabling detection of up to 24 pathogens in a single assay
- RealAccurate
- RespiFinder
- GastroFinder
- STD-Finder
- MeningoFinder
Products and services
- SmartFinder Technology Proprietary multiplex PCR technology platform enabling Single tube Multiplex Amplification in Real-Time (SMART) of up to 24 pathogens in a clinical sample using melting curve analysis. Forms the technical basis for the 2Smart syndromic panel product line used by clinical diagnostic laboratories.
- RealAccurate Technology
- RespiFinder 2Smart
- GastroFinder 2Smart
- STD-Finder 2Smart
- MeningoFinder 2Smart
- RealAccurate Quadruplex Influenza PCR Kit
- RealAccurate Quadruplex Corona PCR Kit
- RealAccurate Quadruplex SARS-CoV-2 PCR Kit
- RealAccurate Quadruplex Parainfluenza PCR Kit
- RealAccurate Quadruplex RSV/hMPV PCR Kit
- RealAccurate Quadruplex Adeno/Boca/Rhino/Entero PCR Kit
- RealAccurate Quadruplex Bordetella PCR Kit
- RealAccurate Quadruplex Atypical Bacteria PCR Kit
- RealAccurate Quadruplex Mycobacteria PCR Kit
Quantifiable outcome
- Diagnosis within 2.5 hours after nucleic acid extraction
- +2 more outcomes
Companies that use PathoFinder B.V.
Customer profileSegments3 records
Ideal customer profiles2 records
PathoFinder B.V. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration27 records
Feature3 records
PathoFinder B.V. partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered regional and core.
- Diagnostic TechnologyregionalDistributor for PathoFinder products in Australia. Located at 61 (0) 2 9986 2011, [email protected]
- ADT-BiotechregionalDistributor for PathoFinder products across multiple Asia Pacific regions including Bangladesh, Hong Kong, Macau, Taiwan, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Thailand, and Vietnam. Contact: +60 379 316 760, [email protected]
- Shanghai GeneoDx BiotechregionalDistributor for PathoFinder products in Chinese Mainland. Contact: [email protected], +86 21 64 96 09 72
- ExoMedicaregionalDistributor for PathoFinder products in Baltic States. Contact: [email protected], +371 66 11 95 93
- RIDACOMregionalDistributor for PathoFinder products in Bulgaria. Contact: [email protected], +359 (0)2 955 99 98
- LABLABregionalDistributor for PathoFinder products in Denmark. Contact: [email protected], +45 40 35 05 50
- XboXLabregionalDistributor for PathoFinder products in Finland, Norway, and Sweden. Contact: [email protected], +358 (0)45 3222 466
- Clonit S.R.L.regionalDistributor for PathoFinder products in Italy. Contact: [email protected], +39 02 5681 4413
- Celtic Molecular DiagnosticsregionalDistributor for PathoFinder products in South Africa. Contact: [email protected], +27 21 762 77 03
- Mobius Life ScienceregionalDistributor for PathoFinder products in Brazil. Contact: [email protected], +55 (41) 3401 18 50
- QCMD (Quality Control for Molecular Diagnostics)coreInternational External Quality Assessment (EQA) provider for molecular diagnosis. PathoFinder participates in all applicable EQA programs for both 2SmartFinder and RealAccurate products. QCMD has extensive EQA portfolio for infectious diseases including schemes for microbial load, genotyping and drug resistance.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
PathoFinder B.V. competitors and assessment
Company assessmentOthers
Direct peers
- QIAGEN (QIAstat-Dx): QIAstat-Dx is a cartridge-based syndromic PCR system competing head-to-head in respiratory, GI and meningitis panels. Same end customers and clinical use cases as PathoFinder, but delivered via an integrated cartridge/instrument platform rather than open-kit PCR reagents.
- Fast Track Diagnostics (Siemens Healthineers): Fast Track Diagnostics, acquired by Siemens Healthineers, supplies a broad syndromic multiplex PCR menu covering respiratory, GI, meningitis, STI and tropical infections — directly comparable panel-by-panel to PathoFinder's 2SmartFinder offerings, with similar open-kit distribution model.
- Seegene: Seegene's Allplex assays are highly multiplexed (20+ targets) syndromic PCR kits for respiratory, GI, STI and meningitis — directly comparable to PathoFinder's 2SmartFinder technology in chemistry philosophy and product breadth. Both sell through global distributor networks.
- bioMérieux (BioFire FilmArray): BioFire FilmArray is the dominant closed-cartridge syndromic PCR system (respiratory, GI, meningitis/encephalitis, blood culture ID panels). Direct overlap with PathoFinder's 2SmartFinder syndromic panels in the same clinical use cases and customer base (hospital/clinical labs), but with an automated sample-to-answer platform.
- DiaSorin (formerly Luminex): DiaSorin's molecular business (including the legacy Luminex xMAP/xTAG portfolio) competes in syndromic respiratory, GI and meningitis testing. Same syndromic testing customer base as PathoFinder, with broader but less-deep multiplexing chemistry.
Emerging players
- Genetic Signatures: Australian molecular diagnostics company with EasyScreen multiplex PCR kits for syndromic respiratory, GI and STI testing. Comparable chemistry and product breadth to PathoFinder, but with a more limited global distribution footprint.
Broad incumbents
- Hologic: Hologic's Panther system and Aptima assays are leading molecular diagnostics for STI/HPV/women's health — directly overlapping with PathoFinder's STD-Finder 2Smart panel in clinical use case and customer base.
- Cepheid (Danaher): GeneXpert is the largest installed-base molecular diagnostics platform globally, including Xpert Xpress respiratory and STI assays. Overlaps with PathoFinder in syndromic and targeted PCR, but Cepheid sells integrated cartridge/instrument systems rather than open kits.
- Abbott Molecular: Abbott's m2000 and Alinity m molecular platforms cover respiratory and STI testing, competing for the same hospital/clinical-lab budget as PathoFinder, though with a closed-system architecture.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
PathoFinder B.V. social profiles
Digital presencePathoFinder B.V. compliance and trust
Trust signalCompliance3 records
PathoFinder B.V. financial estimates
Financial estimateRevenue estimate
Valuation estimate
PathoFinder B.V. leadership team
Management profileNumber of profiles
Profiles3 records
PathoFinder B.V. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PathoFinder B.V. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PathoFinder B.V.
What does PathoFinder B.V. do?
PathoFinder develops, manufactures, and sells CE-IVD marked multiplex real-time PCR diagnostic kits for syndromic detection of infectious diseases. Its portfolio includes RespiFinder 2Smart, GastroFinder 2Smart, STD-Finder 2Smart, and MeningoFinder 2Smart syndromic panels, plus nine targeted RealAccurate Quadruplex kits for specific respiratory and mycobacterial pathogens. Products are sold globally through a distributor network and validated on leading qPCR platforms.
Is PathoFinder B.V. a public or private company?
PathoFinder B.V. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PathoFinder B.V. founded?
PathoFinder B.V. was founded in 2004. It employs 11 to 50 people.
Where is PathoFinder B.V. based?
PathoFinder B.V. is headquartered in Maastricht, Netherlands, in the Europe region.
How does PathoFinder B.V. make money?
One revenue line is on record: CE-IVD Multiplex PCR Kits.
Who are PathoFinder B.V.'s main competitors?
Roche Diagnostics is listed as an others. Direct peers are QIAGEN (QIAstat-Dx), Fast Track Diagnostics (Siemens Healthineers), Seegene, bioMérieux (BioFire FilmArray) and DiaSorin (formerly Luminex). Genetic Signatures is listed as an emerging player. Broad incumbents are Hologic, Cepheid (Danaher) and Abbott Molecular.
Does PathoFinder B.V. have an API?
No public API is recorded for PathoFinder B.V..
What industry is PathoFinder B.V. in?
PathoFinder B.V.'s product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAOAD, Hematology POCT (CBC/hemoglobin/hematocrit), with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.